missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ PLA2G4F Polyclonal Antibody
Description
Recommended positive controls: 293T, A431, Jurkat, Raji. Predicted reactivity: Bovine (81%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
Calcium-dependent phospholipase A2 that selectively hydrolyzes glycerophospholipids in the sn-2 position. Has higher enzyme activity for phosphatidylethanolamine than phosphatidylcholine.
Specifications
Specifications
| Antigen | PLA2G4F |
| Applications | Western Blot, Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | 0.8 mg/mL |
| Conjugate | Unconjugated |
| Formulation | 0.1M tris glycine with 20% glycerol and 0.01% thimerosal; pH 7 |
| Gene | PLA2G4F |
| Gene Accession No. | Q68DD2 |
| Gene Alias | 3.1.1.4; 4732472I07Rik; cPLA2-zeta; cytosolic phospholipase A2 zeta; Gm647; Phospholipase A2 group IVF; phospholipase A2, group IVF; Pla2g4f; PLA2G4FZ; Pla2zeta |
| Gene Symbols | PLA2G4F |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?